[Cite as http://purl.org/au-research/grants/nhmrc/1076172]
Dr Arif Anwar
Dr Elin Gray
Prof Mel Ziman
Brief description Early diagnosis of melanoma remains extremely challenging. Currently there are no validated blood-based biomarkers for early diagnosis. Therefore, a reliable screening test is an unmet medical need. Autoantibodies are emerging as promising biomarkers for early cancer detection. In a proof of principle experiment we identified five autoantibodies that provide 95% sensitivity / specificity. Now we will confirm and validate our findings and develop a clinical test for melanoma diagnosis.
Funding Amount $AUD 461,659.21
Funding Scheme Development Grants